AM Diabetes and Endocrinology Center
Bartlett, Tennessee, United States
Diabetes center in Bartlett, Tennessee
3025 Kate Bond Rd, Bartlett, TN 38133
About AM Diabetes and Endocrinology Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Medtronic Diabetes
6
Mannkind Corporation
4
Novartis
3
Andromeda Biotech Ltd.
1
Boehringer Ingelheim
1
Eli Lilly and Company
1
Janssen Research & Development, LLC
1
MacroGenics
1
Mesoblast, Inc.
1
Clinical Trials at AM Diabetes and Endocrinology Center
During the past decade, AM Diabetes and Endocrinology Center conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 7 clinical trials were completed, i.e. on
average, 77.8% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up
2006-02-01
2008-09-01
Completed
677
Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency
2008-01-01
2010-10-01
Completed
148
PROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)
2008-06-11
2011-12-19
Completed
63
Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency (28-week Extension Study)
2008-09-01
2011-04-01
Completed
75
Efficacy and Long-Term Safety of Vildagliptin as Monotherapy in Patients With Type 2 Diabetes
2008-11-01
2010-10-01
Completed
338
Protege Encore Study- Clinical Trial of Teplizumab (MGA031) in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus
2009-09-01
2012-07-01
Completed
254
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "AM Diabetes and Endocrinology Center" #1 sponsor was "Medtronic Diabetes" with 6 trials, followed by "Mannkind Corporation" with 4 trials
sponsored, "Novartis" with 3 trials sponsored, "Andromeda Biotech Ltd." with 1 trials sponsored and "Boehringer Ingelheim"
with 1 trials sponsored. Other sponsors include -1 different institutions and
companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "AM Diabetes and Endocrinology Center"
#1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Insulet Corporation" with 1 trials as a collaborator, "Jaeb Center for Health Research" with 1 trials as a collaborator and "Juvenile Diabetes Research Foundation" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at AM Diabetes and Endocrinology Center
According to Clinical.Site data, the most researched conditions in "AM Diabetes and Endocrinology Center" are
"Type 1 Diabetes Mellitus" (7 trials), "Diabetes Mellitus, Type 2" (5 trials), "Type 1 Diabetes" (3 trials), "Diabetes Mellitus, Type 1" (2 trials) and "Type 2 Diabetes Mellitus" (2 trials). Many other conditions were trialed in "AM Diabetes and Endocrinology Center" in a lesser frequency.
Clinical Trials Intervention Types at AM Diabetes and Endocrinology Center
Most popular intervention types in "AM Diabetes and Endocrinology Center" are "Drug" (12 trials), "Device" (6 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "vildagliptin" (2 trials), "70% insulin aspart protamine suspension and 30% insulin aspart injection (rDNA origin)" (1 trials), "AHCL insulin pump system" (1 trials) and "Active comparator" (1 trials). Other intervention names were less common.
Clinical Trials Genders at AM Diabetes and Endocrinology Center
The vast majority of trials in "AM Diabetes and Endocrinology Center" are
19 trials for "All" genders.
Clinical Trials Status at AM Diabetes and Endocrinology Center
Currently, there are NaN active trials in "AM Diabetes and Endocrinology Center".
undefined are not yet recruiting,
2 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 15 completed trials in AM Diabetes and Endocrinology Center,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in AM Diabetes and Endocrinology Center, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 11 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 6 trials that are defined as “Not Applicable".